Given the differences in specificity and off target binding that has been studied between the different tracers, it will be important to conduct further research assessing both the sensitivity and specificity of each tau tracer in the context of TBI related tauopathy, particularly across different stages of disease and across diverse populations. Here, MAPT is linked to tauopathy.